Piezo2

Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B)

Spatial tier: RESTRICTED · Class: ION_CHANNEL · Top region: MH (Medial habenula) · Positive regions: 23/554

44.2Discovery Score
38.9Targetability Score
CEvidence grade C
What this means: Piezo2: fine CCF profile is restricted toward MH (top regions: MH, ME, PA, IMD, PR; 23 positive regions); direct spatial validation is still required.

Function in MH: evidence, prediction, innovation

Gene function
PIEZO2 is a very large trimeric mechanically activated cation channel with a propeller-shaped architecture that senses membrane tension directly, without accessory proteins. It is the principal mechanotransducer for light touch, proprioception and several interoceptive reflexes, and human PIEZO2 loss-of-function produces a distinctive syndrome of absent proprioception and touch with preserved nociception.
Region function
The medial habenula is a dorsal diencephalic nucleus whose cholinergic, glutamatergic and substance-P neurons project almost exclusively through the fasciculus retroflexus to the interpeduncular nucleus; it controls nicotine aversion and withdrawal, anxiety and mood.
Published in this region
inferred No region-specific literature found. The only report linking PIEZO2 to this nucleus is a pharmacology study of a traditional-medicine formulation acting on an Epac1-Piezo2 pathway in the medial habenula-interpeduncular system (Wang et al. 2025), which is not a primary characterisation; more broadly, Wang et al. 2021 reported Piezo2 in a select set of central neurons, but the channel's validated biology is in dorsal root ganglia, Merkel cells and urothelium (Woo et al. 2015; Marshall et al. 2020).
Predicted function
Prediction: the medial habenula lies directly against the third ventricle, so PIEZO2 there is predicted to make these neurons sensitive to ventricular pulsation and to osmotic cell-volume change, converting a mechanical or hydration signal into tonic excitatory drive along the fasciculus retroflexus. Conditional Piezo2 deletion in Tac1-Cre or Chat-Cre medial habenula neurons is predicted to abolish stretch-activated currents in MH slices, reduce the aversive and anxiogenic response to osmotic or hypertonic challenge, and blunt nicotine withdrawal severity; the Piezo1/2 agonist Yoda1-like compounds and Jedi peptides, or GsMTx4 block, give complementary acute tests.
Innovation
★★★★★ 5/5 PIEZO2 has essentially no validated central neuronal role, and the medial habenula's periventricular position makes it one of the most plausible and testable places to find one.
Tools
Piezo2 floxed and Piezo2-GFP-IRES-Cre mice; Piezo2-conditional knockout crosses with Tac1-Cre or Chat-Cre; the mechanical blocker GsMTx4 and ruthenium red; Piezo-activating compounds (Jedi1/2 for PIEZO1 as comparators); anti-PIEZO2 antibodies require knockout validation; pressure-clamp and high-speed indentation electrophysiology in slices.
References

Direct evidence located at the region

No Allen ISH section could be located at this region's centroid for the recorded experiments.

Direct spatial evidence

MERFISH REGION LOCATOR
MH MERFISH region locator
Real single-cell MERFISH coordinates for the MH (Medial habenula) section -- our own ground-truth data, showing exactly where this region sits, independent of whether the Allen ISH section below is easy to read.

Regional expression figure

Piezo2 regional expression profile

Predicted WMB × fine-CCF profile; not direct full-transcriptome spatial measurement.

Spatial profile

MH
1.89
ME
1.17
PA
1.1
IMD
1.03
PR
0.997
LRNp
0.973
B
0.964
BMAp
0.942
AT
0.902
POR
0.874
AIp6b
0.846
NTB
0.826
VCO
0.766
VI
0.762
SSp-m1
0.76
AOBgr
0.759
ICB
0.735
MDRNd
0.701
SUT
0.676
LC
0.674

Evidence and specificity

Evidence status
PREDICTED_FINE
Direct sources
None; predicted localization only
Exclusive threshold
12 positive regions out of 554
Spatial specificity
0.284
Top-region fraction
0.058
Filter status
PASS

Interpretation limits